Dr. Daniel Joseph Denucci

DDS | Dentist



  
  2220 Riverside Ave, Minneapolis
  Minnesota, 55454

  612-341-1400    Maps & Directions
Dr. Daniel Joseph Denucci is a Minneapolis, Minnesota based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 2220 Riverside Ave, Minneapolis. Patients can reach him at 612-341-1400.
Dr. Daniel Joseph Denucci is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Daniel Joseph Denucci speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Daniel Joseph Denucci
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:2220 Riverside Ave, Minneapolis,
Minnesota, 55454
Phone:612-341-1400
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7719282441
Enrollment ID: I20180813001441
NPI Number: 1548607666
NPI Enumeration Date: 30 May, 2013
NPI Last Update On: 05 Sep, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2220 Riverside Ave,
Minneapolis, Minnesota
Zip: 55454-1321
Phone Number: 612-341-1400
Patients can reach Dr. Daniel Joseph Denucci at 2220 Riverside Ave, Minneapolis, Minnesota or can call to book an appointment on 612-341-1400. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: